Impact of septal myectomy on diastolic function in patients with obstructive hypertrophic cardiomyopathy

Qiulan Yang1, Hao Cui2, Changsheng Zhu1

  • 1Department of Cardiovascular Surgery, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.

Journal of Thoracic Disease
|September 16, 2021
PubMed

Insights

Septal myectomy significantly improved diastolic function in obstructive hypertrophic cardiomyopathy (HCM) patients. This procedure reduced left ventricular outflow tract obstruction and relieved right ventricular congestion.

Area of Science:

  • Cardiology
  • Cardiac Surgery
  • Hemodynamics

Background:

  • Diastolic function impact post-septal myectomy in obstructive hypertrophic cardiomyopathy (HCM) remains understudied.
  • Obstructive HCM presents challenges in managing cardiac mechanics and patient outcomes.

Purpose of the Study:

  • To evaluate the effect of septal myectomy on left ventricular diastolic function in patients with obstructive HCM.
  • To assess hemodynamic changes, including outflow tract gradients and pulmonary pressures, following the procedure.

Main Methods:

  • A transcatheter hemodynamic study was conducted on 12 obstructive HCM patients.
  • Measurements were taken before and 3-6 months after septal myectomy.

Main Results:

  • Septal myectomy significantly reduced the left ventricular outflow tract gradient (83.2 to 11.6 mmHg).
  • Left ventricular diastolic function improved, indicated by a decreased time constant (Tau) from 64.2 to 42.2 ms.
  • Left atrial pressure and pulmonary artery pressures/resistance decreased, alleviating right ventricular congestion.

Conclusions:

  • Septal myectomy effectively enhances left ventricular diastolic function in obstructive HCM.
  • The procedure leads to significant hemodynamic improvements and relief of right ventricular congestion.
Abstract

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
67
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
96
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
59
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
84
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
105
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
77